secwatch.observer — SEC 8-K summary
======================================

Issuer:     HERON THERAPEUTICS, INC. /DE/ (HRTX)
CIK:        0000818033
Form:       8-K
Filed at:   2024-03-21T23:59:59+00:00
Accession:  0001193125-24-073897
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Heron Therapeutics designates Ira Duarte as principal accounting officer, replacing Lisa Peraza
--------------------------------------------------------------------------------

- Ira Duarte appointed principal accounting officer effective March 29, 2024, succeeding Lisa Peraza.
- Lisa Peraza will remain as chief accounting officer until her employment ends on the effective date.
- No additional compensation or adjustments for Duarte in connection with the new role.
- Duarte already serves as EVP and CFO; no family relationships or related party transactions with the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818033/000119312524073897/0001193125-24-073897-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818033/000119312524073897/d801406d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-073897

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer